Latest Press Releases

Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha that's given orally in low doses, making it safer and less expensive than current injectable formulations.

Amarillo Biosciences is working with global partners to conduct clinical studies to establish the safety and efficacy of low-dose interferon-alpha given in the form of orally dissolving lozenges to treat a number of significant human diseases, including influenza and hepatitis C

• Enhances Salivary Function
• Promotes Oral Comfort
• Helps Relieve Dry Mouth

Get More Information on MAXISAL®

Current Stock Value
Loading
Chart
OTC:AMAR

Amarillo Biosciences

Company ID [OTC:AMAR] Last trade:0.04 Trade time:3:38PM EST Value change: (%)
Syndicate
feed-image Feed Entries
Copyright © 2014 Amarillo Biosciences. All Rights Reserved.
Built and hosted by Dark Roast Hosting